Company intelligence / Profile preview

Choseido Pharmaceutical

Tokushima, Tokushima-ken, Japan

Ownership: Private
Development stage: Other

Overview

Choseido Pharmaceutical is one of Japan’s leading manufacturers of generic antibiotics, especially cephem antibiotics, accounting for ~70% of generic cephems in Japan; several small molecule drugs are approved and in use for various indications. The firm has recently faced severe manufacturing and GMP compliance issues that have disrupted the antibiotic supply chain and resulted in recalls and plant halts[10].

Therapeutic areas: NephrologyEndocrinologyInfectious DiseasesHematologyDermatologyPulmonologyNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

glutathione (Lisapharma)

Unknown

Partnerships

Contract manufacturing for multiple Japanese pharma firms for cephem antibiotics and other generics

Beyond the preview

Go deeper on Choseido Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Choseido Pharmaceutical.

Explore the full profile